next stop .25, page-20

good to hear from you guys ...

PBIOA's are an amazing option .... .05 at present with .20 to pay in 2012 ..... I would imagine a .10 discount is probably not too far fetched given that time to expiry and the growth prospects PBI has.

Ice correctly flags the UK legislation that will make it mandatory for surgeons there to regularly be re-trained in order to keep their licence. Fundamental shift in how surgeons are assessed and will result in big dollars for a company that will be paid to design, set up and operate the training centres. Look long term people. This is a stock with huge potential ... and they have few competitors. There's been some growing pains, many false starts, but look at the charts of resmed, csl and cochlear ... PBI could well emulate these mainstays of the australian life science sector..